Nucleic-acid based gene therapy approaches for sepsis.

Area of Science:

• Molecular Medicine
• Genetics
• Critical Care Medicine

Background:

• Sepsis remains a significant clinical challenge with high mortality rates.
• Current treatments for sepsis and its complications are limited, necessitating innovative therapeutic strategies.

Purpose of the Study:

• To review current gene-targeting approaches for sepsis treatment developed in animal models.
• To explore the potential of gene therapy as a novel therapeutic strategy for sepsis.

Main Methods:

• Review of existing literature on gene therapy applications in sepsis models.
• Analysis of the molecular mechanisms underlying sepsis pathology, focusing on gene regulation.

Main Results:

• Identification of key transcription factors (e.g., NF-κB, AP-1) involved in sepsis pathogenesis.
• Demonstration of gene therapy's potential in preclinical sepsis models.

Conclusions:

• Sepsis can be viewed as a gene-related disorder, making gene therapy a viable therapeutic avenue.
• Future research should prioritize the development and clinical translation of gene therapy for sepsis.